Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given written consent to participate (or whose legal representative has done so on their behalf)
- People aged 18 or older
- People who have a reasonable level of physical functioning, as measured by a standard health scale called the Karnofsky Performance Status (score of 60 or above) (confirm with trial site)
- People who can read and understand English or Spanish, or who are able to complete questionnaires with the help of a certified interpreter
- People who have been diagnosed with breast cancer or non-small cell lung cancer, confirmed through a tissue sample
- People whose cancer has spread to the lining around the brain and spinal cord (called leptomeningeal disease), confirmed by scan or spinal fluid test
- People whose blood counts and kidney function meet certain minimum levels, including white blood cells, red blood cells, platelets, and kidney filtering ability (confirm with trial site for specific values)
- Women who could become pregnant must have a negative pregnancy test before starting the trial
- People of childbearing potential who agree to use effective birth control or avoid heterosexual activity during the trial and for at least one month after the last treatment
Who may not be able to join:
- People who have received chemotherapy, biological therapy, or immunotherapy within 7 days before the trial start date
- People whose prior radiation treatment, in the opinion of the treating doctor, would make it unsafe to receive radiation to the brain and spine as part of this trial
- People who have multiple or serious neurological symptoms, such as confusion or brain swelling, as determined by the treating doctor
- People who have widespread cancer outside the brain and spine that is not under control
- People for whom, in the treating doctor's opinion, there are no reasonable remaining treatment options for their cancer overall
- People with other serious uncontrolled medical conditions, as determined by the treating doctor
- People with a history of HIV infection, unless they are on effective treatment and their viral load has been undetectable within the past 6 months
- People with a history of chronic hepatitis B infection, unless their viral load is undetectable and they are on suppressive therapy
- People with a history of hepatitis C infection, unless they have been successfully treated and cured, or are currently on treatment with an undetectable viral load
- People with another active cancer, unless the treating doctor considers it unlikely to interfere with the safety or results of this trial
- People who are pregnant or breastfeeding
- People who are unable to have an MRI scan of the brain and spine with contrast dye (gadolinium)
- People who, in the treating doctor's opinion, may not be able to follow all study procedures for any reason
- People with any other condition that the treating doctor considers would make participation unsafe
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Central nervous system (CNS)-progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.